Business Post logo
  • SUBSCRIBE
  • Log
  • menu
  • menu
  • Brexit
  • Coronavirus
  • Companies
  • Data
  • US
  • SMEs
  • Health
  • Legal
  • Climate & Environment
  • Housing
  • Podcasts
  • Focus On
  • Crosswords
Close menu
  • News
  • Politics
  • News Focus
  • Analysis & Opinion
  • Tech
  • Life & Arts
  • Property
  • Food & Wine
  • Irish Tatler
  • Benefits

Cannabis

Up for Debate

Up for debate: The best from the Business Post’s columnists

Insightful analysis of the main developments in business and politics from our team of writers, including Elaine Byrne, Matt Cooper and Ian Guider
  • Business Post
  • November 20, 2022
Comment

Elaine Byrne: We need to talk about cannabis, and about legalising it in Ireland

Gino Kenny’s bill to legalise cannabis for personal use presents a timely opportunity to discuss the realities around cannabis and its use today
  • Elaine Byrne
  • November 19, 2022
Business

Cowen-linked cannabis and cryptocurrency firm to raise $4m

Company with Brian Cowen on its advisory board plans to become the ‘Amazon of Cannabis’ and eliminate cash from legal cannabis purchases
  • Barry J Whyte
  • November 12, 2022
Companies

Cowen back on board of Canadian cannabis and cryptocurrency firm

The former taoiseach had previously been on the advisory board of GetTangi Corporation, and has now returned following his 2019 stroke
  • Barry J Whyte
  • August 13, 2022
Social Affairs

Elaine Byrne: Anti-cannabis group has its say, but minister needs to listen to the other side

Frank Feighan, the minister in charge of the National Drugs Strategy, does not envisage legalising cannabis, but a legally regulated market would control what goes into cannabis, as well as generating revenue from taxes
  • Elaine Byrne
  • July 23, 2022
legal

Businessman secures stay on his prosecution for possessing cannabis products with trace amounts of THC

Judge says state must prove its prohibitions on cannabis products containing trace amounts of the psychoactive compound protect human health
  • Catherine Sanz
  • May 18, 2022

State says legalising cannabis products containing THC is ‘premature’

The claim appeared in a legal challenge to the no-tolerance policy in Irish law for products containing the main psychoactive compound in cannabis
  • Catherine Sanz
  • January 23, 2022

Jazz Pharmaceuticals wins approval for HSE reimbursement of cannabis-derived drug

The company acquired GW Pharma, the UK biopharma and producer of cannabis-derived Epidiolex, earlier this year
  • Eva Short
  • December 9, 2021

Elaine Byrne: Our conservative approach to medical cannabis is prolonging people’s suffering

The licensing of cannabis medication is overly bureaucratic, the products are expensive and reimbursement limited, so some individuals are risking prosecution by growing their own
  • Elaine Byrne
  • September 12, 2021

Elaine Byrne: We need an honest debate on whether banning cannabis is more harmful than legalising it

The war on drugs has been a spectacular and costly failure, and it’s time to face reality instead of continuing our usual approach of ‘blissful ignorance’
  • Elaine Byrne
  • August 27, 2021

Irish hemp farmers are operating in a legal grey area

Farmers and industry representatives say Irish law is holding back the development of a large-scale hemp industry, due to a no-tolerance policy over the cannabinoid compound THC, which forms part of the plant
  • Catherine Sanz
  • August 15, 2021

Matt Cooper: Falling house of cards could take this government with it

The housing crisis hasn’t gone away, you know. It was only a matter of time until the fund-warped development model came back to bite those currently in power
  • Matt Cooper
  • May 9, 2021

Business Post
Contact
Privacy Policy
Terms of Use
Data Access Request
Follow us
Download the app
Business Post Google App
Business Post iOS App
Part of the
Business Post Group